Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Zimmer Holdings
(NY:
ZBH
)
95.33
-2.16 (-2.22%)
Official Closing Price
Updated: 4:10 PM EDT, May 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zimmer Holdings
< Previous
1
2
3
4
5
6
7
8
9
Next >
Boston Scientific: Why This MedTech Giant Isn’t Slowing Down
September 17, 2024
Boston Scientific Co (NYSE: BSX) is a global medical device manufacturer that’s seeing a strong influx of investors as shares grind to new all-time highs.
Via
MarketBeat
Oracle To Rally Around 23%? Here Are 10 Top Analyst Forecasts For Friday
September 13, 2024
Via
Benzinga
Navigating 14 Analyst Ratings For Zimmer Biomet Holdings
September 05, 2024
Via
Benzinga
Zimmer Biomet Hammered, Sales Expected To Take A Surprise 1% Hit
September 05, 2024
The company is well known for its hip and knee replacements. Full-year sales will take an unexpected hit.
Via
Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
August 15, 2024
Via
Benzinga
Assessing Zimmer Biomet Holdings: Insights From 8 Financial Analysts
August 08, 2024
Via
Benzinga
Where Zimmer Biomet Holdings Stands With Analysts
July 01, 2024
Via
Benzinga
Peering Into Zimmer Biomet Holdings's Recent Short Interest
June 25, 2024
Via
Benzinga
Is PROCEPT BioRobotics the Next Big Thing in Surgical Robotics?
August 14, 2024
Surgical robotics company PROCEPT BioRobotics Co. (NASDAQ: PRCT) developed the AquaBeam Robotic System for the treatment of benign prostatic hyperplasia
Via
MarketBeat
ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q2 2024
August 07, 2024
ZBH stock results show that Zimmer Biomet Holdings beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Medical Technology Stock Benefits from Rising Acute Care Demand
August 07, 2024
Medical and surgical products manufacturer Stryker Co. (NYSE: SYK) is a beneficiary of the acute care boom occurring in the healthcare industry.
Via
MarketBeat
Topics
Supply Chain
Exposures
Supply Chain
Why Intuitive Surgical Stock is Dominating the Medical Sector
August 06, 2024
Robotic surgery conjures up futuristic images of automated machines performing surgery on anesthetized human patients in an assembly line. However
Via
MarketBeat
In-Depth Examination Of 6 Analyst Recommendations For Zimmer Biomet Holdings
May 21, 2024
Via
Benzinga
Analyst Expectations For Zimmer Biomet Holdings's Future
May 03, 2024
Via
Benzinga
3 Healthcare Stocks to Buy at a 52-Week Low in July
July 29, 2024
At their 52-week lows, these undervalued healthcare stocks present a favorable return supported by healthcare spending tailwinds.
Via
InvestorPlace
ZimVie Stock Launches 15% Into Breakout Territory On Rumored Takeover
July 18, 2024
The company spun out from Zimmer Biomet in 2022. Now, it's a possible takeover candidate.
Via
Investor's Business Daily
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
June 21, 2024
The Benzinga Stock Whisper highlights five stocks that caught an increased amount of attention from readers and investors during the week.
Via
Benzinga
Orthopedic Implants Maker Zimmer Biomet Gains Analyst Upgrade Amid Promising Growth From New Products, Demographic Trends
May 21, 2024
Zimmer Biomet receives an upgrade from Argus Research due to new product launches and strategic acquisitions.
Via
Benzinga
Top Stock Reports For Amazon.com, Visa & Pfizer
May 10, 2024
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com, Inc., Visa Inc.. and Pfizer Inc.
Via
Talk Markets
Unveiling 7 Analyst Insights On Zimmer Biomet Holdings
April 03, 2024
Via
Benzinga
What 7 Analyst Ratings Have To Say About Zimmer Biomet Holdings
February 09, 2024
Via
Benzinga
Why Is Zimmer Biomet Stock Trading Lower Today?
February 08, 2024
Zimmer Biomet's Q4 2023 results, featuring 6.3% Y/Y net sales growth, $2.20 adjusted EPS, and a global restructuring plan for $200M cost savings.
Via
Benzinga
(ZBH) - Analyzing Zimmer Biomet Holdings's Short Interest
February 08, 2024
Via
Benzinga
What's Going On With Zimmer Biomet Shares After Q1 Earnings?
May 02, 2024
Zimmer Biomet beats Q1 earnings and sales estimates, with adjusted EPS at $1.94 and quarterly sales hitting $1.889 billion, prompting a slight dip in shares.
Via
Benzinga
Worried About Inflation? 3 Stocks Built to Thrive in a High-Price Environment
May 02, 2024
With prices remaining elevated above historical norms, investors still are interested in buying inflation-resistant stocks.
Via
InvestorPlace
ZBH Stock Earnings: Zimmer Biomet Holdings Beats EPS, Beats Revenue for Q1 2024
May 02, 2024
ZBH stock results show that Zimmer Biomet Holdings beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via
InvestorPlace
Intuitive Surgical Leads the Robotic Surgery Movement
April 22, 2024
Intuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher
Via
MarketBeat
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
7 Robotic Surgery Stocks to Buy for the Future of Healthcare
March 13, 2024
Discover seven robotic surgery stocks primed for growth as the industry evolves. Unveil opportunities in a market set to double by 2033.
Via
InvestorPlace
Earnings Scheduled For February 8, 2024
February 08, 2024
Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share on revenue of $864.54 million.
Via
Benzinga
Blackstone, Zimmer Biomet And A Membership Warehouse Retailer: CNBC's 'Final Trades'
February 01, 2024
On CNBC’s "Halftime Report Final Trades," Jason Snipe of Odyssey Capital Advisors said he likes Blackstone Inc. (NYSE: BX) here, despite the firm's
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.